Smart move here...seem to be using Aussie quality portfolio as leverage for bigger.. 10mill-50mill oz projects in Asia.. In my opinion will be worth the wait.. Cheers
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status